BBI Cambridge News

The Biotechnology Business Institute Cambridge (BBI Cambridge) is pleased to have nominated Mark Treherne for the 2026 One Nucleus Awards for his networking that has advanced industry-aligned education across the life sciences sector.

Our participation in the MedTech World Middle East event marks a significant strategic action in our expansion efforts in the Middle East. This event has proven to be a successful platform for networking, showcasing innovations, and exploring new opportunities in the MedTech sector.

MedTech World Middle East 2026 is a premier conference that unites over 800 global leaders in the healthcare and technology sectors for three days of collaboration and innovation. Set against the stunning backdrop of Dubai, the event serves as a dynamic platform for industry stakeholders to engage in discussions about the future of medical technology. The conference features a blend of networking opportunities, informative sessions, and showcases of cutting-edge innovations d

In today’s fast-evolving world, building a successful career in Life Sciences requires more than academic excellence. Early professional development, combined with international exposure and the opportunity to expand one’s network, is essential for aspiring leaders in the biotechnology and pharmaceutical sectors.

Cambridge, UK, October 2025 – The Biotechnology Business Institute Cambridge (BBI Cambridge) proudly announces the launch of its Ambassador Programme, a strategic initiative designed to inspire global engagement and advance international collaboration within the biotechnology and life sciences sectors.

Kraków, Poland – 30–31 October 2025 – The 12th Central European Life Sciences Conference (LSBC 2025) concluded with resounding success, bringing together leading investors, entrepreneurs, and scientists from across Europe. Held under the theme “DNA of Capital – Cracking the Code of Life Science Investment in Volatile Times”, the event showcased the resilience, creativity, and investment potential of the European biotechnology and healthcare sectors.